Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DCTH
3126
DELISTED
Delcath Systems Inc
DCTH
| $148K | ﹤0.01% |
+59,914
| New | +$233K |
2016 Q3
0 quarters
|
|
|
PW
3127
Power REIT
PW
$2.55M
| $147K | ﹤0.01% |
1,810
+290
| +19% | +$21.7K |
2013 Q2
13 quarters
|
|
3128
Enlivex Ltd
ENLV
$5.06M
| $146K | ﹤0.01% |
141
+101
| +253% | +$103K |
2016 Q2
1 quarter
|
|
|
AGRX
3129
DELISTED
Agile Therapeutics
AGRX
| $144K | ﹤0.01% |
+10
| New | +$143K |
2016 Q3
0 quarters
|
|
|
NBSE
3130
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $143K | ﹤0.01% |
127
+72
| +131% | +$77.7K |
2016 Q2
1 quarter
|
|
|
FPP
3131
DELISTED
FieldPoint Petroleum Corporation
FPP
| $142K | ﹤0.01% |
244,400
+900
| +0.4% | +$627 |
2013 Q2
13 quarters
|
|
|
SJT
3132
San Juan Basin Royalty Trust
SJT
$177M
| $141K | ﹤0.01% |
23,825
+8,700
| +58% | +$54.6K |
2015 Q4
3 quarters
|
|
|
QUOT
3133
DELISTED
Quotient Technology Inc
QUOT
| $141K | ﹤0.01% |
+10,600
| New | +$141K |
2016 Q3
0 quarters
|
|
3134
Retractable Technologies
RVP
$19.9M
| $138K | ﹤0.01% |
54,100
+9,000
| +20% | +$22.8K |
2014 Q4
7 quarters
|
|
|
ABAC
3135
DELISTED
Renmin Tianli Group, Inc. Common Shares
ABAC
| $138K | ﹤0.01% |
71,275
+8,675
| +14% | +$24.2K |
2014 Q3
8 quarters
|
|
|
VII
3136
DELISTED
Vicon Industries, Inc.
VII
| $137K | ﹤0.01% |
193,300
+59,600
| +45% | +$45.1K |
2013 Q2
13 quarters
|
|
3137
Lisata Therapeutics
LSTA
$11.5M
| $135K | ﹤0.01% |
1,943
+1,861
| +2,270% | +$150K |
2016 Q2
1 quarter
|
|
3138
Network-1 Technologies
NTIP
$35.9M
| $135K | ﹤0.01% |
49,600
+39,484
| +390% | +$106K |
2016 Q2
1 quarter
|
|
3139
Citizens
CIA
$176M
| $134K | ﹤0.01% |
14,300
-22,800
| -61% | -$212K |
2016 Q1
2 quarters
|
|
|
DXTR
3140
DELISTED
Dextera Surgical Inc.
DXTR
| $133K | ﹤0.01% |
70,672
+5,500
| +8% | +$11.7K |
2016 Q2
1 quarter
|
|
|
ACUR
3141
DELISTED
Acura Pharmaceuticals
ACUR
| $131K | ﹤0.01% |
81,920
+6,300
| +8% | +$11.2K |
2014 Q2
9 quarters
|
|
3142
Danaos Corp
DAC
$3.08B
| $130K | ﹤0.01% |
+3,464
| New | +$175K |
2016 Q3
0 quarters
|
|
3143
Solitario Resources
XPL
$54M
| $130K | ﹤0.01% |
196,575
+55,975
| +40% | +$42.9K |
2015 Q4
3 quarters
|
|
|
JMP
3144
DELISTED
JMP Group LLC
JMP
| $129K | ﹤0.01% |
23,333
+4,270
| +22% | +$23.8K |
2015 Q2
5 quarters
|
|
|
AMPE
3145
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $128K | ﹤0.01% |
+579
| New | +$162K |
2016 Q3
0 quarters
|
|
|
PTN
3146
Palatin Technologies
PTN
$15.3M
| $126K | ﹤0.01% |
160
-14
| -8% | -$9.83K |
2015 Q1
6 quarters
|
|
|
HSTO
3147
DELISTED
Histogen Inc. Common Stock
HSTO
| $125K | ﹤0.01% |
+313
| New | +$128K |
2016 Q3
0 quarters
|
|
|
MTL.PR
3148
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
| $124K | ﹤0.01% |
222,800
+1,900
| +0.9% | +$718 |
2013 Q2
13 quarters
|
|
|
RNVA
3149
DELISTED
Rennova Health, Inc.
RNVA
| $123K | ﹤0.01% |
1,448
+1,394
| +2,581% | +$183K |
2016 Q1
2 quarters
|
|
|
JASN
3150
DELISTED
Jason Industries, Inc.
JASN
| $122K | ﹤0.01% |
55,000
+24,400
| +80% | +$67.5K |
2016 Q1
2 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.